Navigation
Home

Login

How

Why

Who

Thanks


Start Bookmarking

Search Tags

 

 


What's Buzzing

 

What's News

 

What's News + Buzzing

 

Disclaimers

© Copyright OTD 2005, All Rights Reserved

Design by Smallpark

 

Tag Directory > Investigational New Drug


We have 3 results for Investigational New Drug.

Drug Development: From Discovery to NDA

1 Citation
Introduction The time it takes from starting a program to selling a product can vary but is usually estimated to be around 10 years and the total cost associated with bringing a drug to market is widely cited to be at least $850 million. These numbers outline high stakes and whether you are an investor or just new to the industry, it is crucial to understand the basic path from bench to bedside. This review isn?t meant to be a discussion filled with nuance and detail (frankly, I don?t know a, technorati.com

 

FDA Rule and Companion Guidance Make Early Stage Clinical Drug Development Safe and Efficient

1 Citation
The U.S. Food and Drug Administration today issued a final regulation that makes early phase 1 clinical drug development safe and efficient by enabling a phased approach to complying with current good manufacturing practice (CGMP) statutes and FDA investigational requirements. To facilitate this new approach, the regulation exempts most phase 1 investigational drugs from the requirements in 21 CFR part 211 ? FDA will continue to exercise oversight of the manufacture of these drugs under FDA?s, technorati.com

 

Herpes zoster virus. Eye drops. ?? used to treat four neurotrophic keratitis patients with non-healing eye ulcers caused primarily by the herpes zoster virus under a ?Compassionate Use? IND ??

1 Citation
RegeneRx Biopharmaceuticals Inc has reported: ?? that its ophthalmic drug candidate, RGN-259, was used to treat four neurotrophic keratitis patients with non-healing eye ulcers caused primarily by the herpes zoster virus under a ?Compassionate Use? IND (Investigational New Drug application).? ?RGN-259 is a sterile eye drop formulation of TB4 being developed by RegeneRx for use in treating ophthalmic wounds and related disorders.? More from a Release dated November 17, sourced from RegeneRx, technorati.com

 


Powered by Odin Assemble